Phibro Animal Health Corporation (PAHC)
- Previous Close
12.56 - Open
12.43 - Bid 12.41 x 200
- Ask 12.47 x 200
- Day's Range
12.30 - 12.62 - 52 Week Range
9.40 - 15.96 - Volume
117,209 - Avg. Volume
144,345 - Market Cap (intraday)
503.865M - Beta (5Y Monthly) 0.74
- PE Ratio (TTM)
33.62 - EPS (TTM)
0.37 - Earnings Date May 8, 2024
- Forward Dividend & Yield 0.48 (3.86%)
- Ex-Dividend Date Mar 5, 2024
- 1y Target Est
10.75
Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs. It also offers animal health products, such as antibacterials, anticoccidials, nutritional specialty, and vaccines and vaccine adjuvants for animal's health and performance, food safety, and animal welfare; and engages in development, manufacturing, and marketing of microbial and bioproducts for various applications serving animal health and nutrition, industrial, environmental, and agricultural customers. In addition, the company develops, manufactures, and markets conventionally licensed and autogenous vaccine products, as well as adjuvants for animal vaccine manufacturers. Further, it provides formulations and concentrations of trace minerals, such as zinc, manganese, copper, iron, and other compounds to fortify the daily feed requirements of their livestock's diets and maintain optimal balance of trace elements in animals. Additionally, the company offers specialty ingredients for personal care, industrial chemical, and chemical catalyst industries. It sells its animal health and mineral nutrition products through local sales offices to integrated poultry, swine, and cattle integrators, as well as through commercial animal feed manufacturers, wholesalers, and distributors. The company was formerly known as Philipp Brothers Chemicals, Inc. and changed its name to Phibro Animal Health Corporation in July 2003. Phibro Animal Health Corporation was founded in 1946 and is headquartered in Teaneck, New Jersey.
www.pahc.com1,920
Full Time Employees
June 30
Fiscal Year Ends
Sector
Recent News: PAHC
Performance Overview: PAHC
Trailing total returns as of 4/25/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: PAHC
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: PAHC
Valuation Measures
Market Cap
503.86M
Enterprise Value
924.47M
Trailing P/E
33.62
Forward P/E
10.03
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.51
Price/Book (mrq)
1.86
Enterprise Value/Revenue
0.94
Enterprise Value/EBITDA
11.05
Financial Highlights
Profitability and Income Statement
Profit Margin
1.51%
Return on Assets (ttm)
3.72%
Return on Equity (ttm)
5.49%
Revenue (ttm)
982.01M
Net Income Avi to Common (ttm)
14.8M
Diluted EPS (ttm)
0.37
Balance Sheet and Cash Flow
Total Cash (mrq)
104.84M
Total Debt/Equity (mrq)
189.47%
Levered Free Cash Flow (ttm)
38.29M
Research Analysis: PAHC
Company Insights: PAHC
Fair Value
Dividend Score
Hiring Score
Insider Sentiment Score
Research Reports: PAHC
PAHC: What does Argus have to say about PAHC?
PHIBRO ANIMAL HEALTH CORP-A has an Investment Rating of HOLD; a target price of $14.000000; an Industry Subrating of Low; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Medium; a Growth Subrating of Medium; and a Value Subrating of Medium.
RatingPrice TargetPAHC: What does Argus have to say about PAHC?
PHIBRO ANIMAL HEALTH CORP-A has an Investment Rating of HOLD; a target price of $14.000000; an Industry Subrating of Low; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Medium; a Growth Subrating of Medium; and a Value Subrating of Medium.
RatingPrice TargetPAHC: Raising target price to $14.00
PHIBRO ANIMAL HEALTH CORP-A has an Investment Rating of HOLD; a target price of $14.000000; an Industry Subrating of Low; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Medium; a Growth Subrating of Medium; and a Value Subrating of Medium.
RatingPrice TargetPAHC: What does Argus have to say about PAHC?
PHIBRO ANIMAL HEALTH CORP-A has an Investment Rating of HOLD; a target price of $13.000000; an Industry Subrating of Low; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Medium; a Growth Subrating of Medium; and a Value Subrating of Medium.
RatingPrice Target